Because actinomycosis is an infection with various manifestations, clinical features vary. Actinomycetes acquire pathogenicity through invasion of breached or necrotic tissue. Once infection is established, the host mounts an intense inflammatory response (i.e., with suppuration and granuloma formation). Fibrosis may then follow. Infection typically spreads contiguously and invades surrounding tissues or organs. Ultimately, the infection produces draining sinus tracts, which are a hallmark of the infection.[1]Smego RA Jr, Foglia G. Actinomycosis. Clin Infect Dis. 1998 Jun;26(6):1255-61.
http://www.ncbi.nlm.nih.gov/pubmed/9636842?tool=bestpractice.com
[4]Acevedo F, Baudrand R, Letelier LM, et al. Actinomycosis: a great pretender: case reports of unusual presentations and a review of the literature. Int J Infect Dis. 2008 Jul;12(4):358-62.
http://www.ncbi.nlm.nih.gov/pubmed/18164641?tool=bestpractice.com
[7]Wong VK, Turmezei TD, Weston VC. Actinomycosis. BMJ. 2011 Oct 11;343:d6099.
http://www.ncbi.nlm.nih.gov/pubmed/21990282?tool=bestpractice.com
[8]Weese WC, Smith IM. A study of 57 cases of actinomycosis over a 36-year period: a diagnostic 'failure' with good prognosis after treatment. Arch Intern Med. 1975 Dec;135(12):1562-8.
http://www.ncbi.nlm.nih.gov/pubmed/1200725?tool=bestpractice.com
[13]Brown JR. Human actinomycosis: a study of 181 subjects. Hum Pathol. 1973 Sep;4(3):319-30.
http://www.ncbi.nlm.nih.gov/pubmed/4756858?tool=bestpractice.com
[14]Cintron JR, Del Pino A, Duarte B, et al. Abdominal actinomycosis. Dis Colon Rectum. 1996 Jan;39(1):105-8.
http://www.ncbi.nlm.nih.gov/pubmed/8601346?tool=bestpractice.com
[15]Ferrari TC, Couto CA, Murta-Oliveira C, et al. Actinomycosis of the colon: a rare form of presentation. Scand J Gastroenterol. 2000 Jan;35(1):108-9.
http://www.ncbi.nlm.nih.gov/pubmed/10672844?tool=bestpractice.com
[16]Yeguez JF, Martinez SA, Sands LR, et al. Pelvic actinomycosis presenting as malignant large bowel obstruction: a case report and a review of the literature. Am Surg. 2000 Jan;66(1):85-90.
http://www.ncbi.nlm.nih.gov/pubmed/10651355?tool=bestpractice.com
[17]Schaal KP, Lee HJ. Actinomycete infections in humans: a review. Gene. 1992 Jun 15;115(1-2):201-11.
http://www.ncbi.nlm.nih.gov/pubmed/1612438?tool=bestpractice.com
[18]Valour F, Sénéchal A, Dupieux C, et al. Actinomycosis: etiology, clinical features, diagnosis, treatment, and management. Infect Drug Resist. 2014 Jul 5;7:183-97.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094581
http://www.ncbi.nlm.nih.gov/pubmed/25045274?tool=bestpractice.com
Infections are seen most commonly in the cervicofacial area (50% to 70%), followed by the abdomen and pelvis (10% to 20%).[13]Brown JR. Human actinomycosis: a study of 181 subjects. Hum Pathol. 1973 Sep;4(3):319-30.
http://www.ncbi.nlm.nih.gov/pubmed/4756858?tool=bestpractice.com
[19]Kwartler JA, Limaye A. Pathologic quiz case 1: cervicofacial actinomycosis. Arch Otolaryngol Head Neck Surg. 1989 Apr;115(4):524-7.
http://www.ncbi.nlm.nih.gov/pubmed/2923698?tool=bestpractice.com
[20]Das N, Lee J, Madden M, et al. A rare case of abdominal actinomycosis presenting as an inflammatory pseudotumour. Int J Colorectal Dis. 2006 Jul;21(5):483-4.
http://www.ncbi.nlm.nih.gov/pubmed/15942743?tool=bestpractice.com
Other manifestations, such as thoracic, hepatic or CNS actinomycosis, are much rarer and are found only as sporadic case reports.[21]Bastian A, Khanavkar B, Scherff A, et al. Thoracic actinomycosis: diagnostic pitfalls and therapeutic considerations. Pneumologie. 2009 Feb;63(2):86-92.
http://www.ncbi.nlm.nih.gov/pubmed/19219769?tool=bestpractice.com
[22]Mabeza GF, Macfarlane J. Pulmonary actinomycosis. Eur Respir J. 2003 Mar;21(3):545-51.
http://erj.ersjournals.com/cgi/content/full/21/3/545
http://www.ncbi.nlm.nih.gov/pubmed/12662015?tool=bestpractice.com
[23]Slade PR, Slesser BV, Southgate J. Thoracic actinomycosis. Thorax. 1973 Jan;28(1):73-85.
http://www.ncbi.nlm.nih.gov/pubmed/4568119?tool=bestpractice.com
[24]Smego RA Jr. Actinomycosis of the central nervous system. Rev Infect Dis. 1987 Sep-Oct;9(5):855-65.
http://www.ncbi.nlm.nih.gov/pubmed/3317731?tool=bestpractice.com
[25]Sundaram C, Purohit AK, Prasad VS, et al. Cranial and intracranial actinomycosis. Clin Neuropathol. 2004 Jul-Aug;23(4):173-7.
http://www.ncbi.nlm.nih.gov/pubmed/15328882?tool=bestpractice.com
[26]Yang XX, Lin JM, Xu KJ, et al. Hepatic actinomycosis: report of one case and analysis of 32 previously reported cases. World J Gastroenterol. 2014 Nov 21;20(43):16372-6.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239533
http://www.ncbi.nlm.nih.gov/pubmed/25473199?tool=bestpractice.com
Cervicofacial actinomycosis often starts after a tissue injury or orofaciomaxillary trauma. In its initial stages it is characterised by soft-tissue swelling of the perimandibular area. Spread occurs over time into adjacent tissues. As a consequence of infection, fistulae (sinus tracts) develop, and these discharge purulent material containing granules with a yellow sulfur-like appearance (termed sulfur granules). Invasion of the cranium or the bloodstream is seen very rarely, but may occur if the disease is misdiagnosed or left untreated.[13]Brown JR. Human actinomycosis: a study of 181 subjects. Hum Pathol. 1973 Sep;4(3):319-30.
http://www.ncbi.nlm.nih.gov/pubmed/4756858?tool=bestpractice.com
[17]Schaal KP, Lee HJ. Actinomycete infections in humans: a review. Gene. 1992 Jun 15;115(1-2):201-11.
http://www.ncbi.nlm.nih.gov/pubmed/1612438?tool=bestpractice.com
Actinomycosis frequently follows surgery. The disease tends to spread locally in a contiguous fashion, disregarding tissue borders. Lymphadenopathy is not typical, and haematogenous dissemination is rare. Because of the slow growth of the pathogen, disease may develop over months to years before diagnosis is made.[13]Brown JR. Human actinomycosis: a study of 181 subjects. Hum Pathol. 1973 Sep;4(3):319-30.
http://www.ncbi.nlm.nih.gov/pubmed/4756858?tool=bestpractice.com
[17]Schaal KP, Lee HJ. Actinomycete infections in humans: a review. Gene. 1992 Jun 15;115(1-2):201-11.
http://www.ncbi.nlm.nih.gov/pubmed/1612438?tool=bestpractice.com